CARLO STELLA, CARMELO
CARLO STELLA, CARMELO
Dipartimento Scienze Biomediche
[Mesenchymal stem cells: biology and clinical applications]
2002-01-01 Carlo-Stella, Carmelo; Di Nicola, Massimo; Gianni, Massimo A
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments
2009-01-01 Righi, M.; Giacomini, A.; Lavazza, C.; Sia, D.; Carlo-Stella, C.; Gianni, A.
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K delta/gamma Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study
2020-01-01 Carlo Stella, C; Delarue, R; Scarfo, L; Barde, Pj; Nair, A; Locatelli, Sl; Morello, L; Magagnoli, M; Vakkalanka, S; Viswanadha, S; Ferreri, Ajm
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
2019-01-01 Kahl, Bs; Hamadani, M; Radford, J; Carlo Stella, C; Caimi, P; Reid, E; Feingold, Jm; Ardeshna, Km; Solh, M; Heffner, Lt; Ungar, D; He, S; Boni, J; Havenith, K; O'Connor, Oa
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma
2021-01-01 Balzarotti, Monica; Magagnoli, Massimo; Canales, Miguel Ángel; Corradini, Paolo; Grande, Carlos; Sancho, Juan-Manuel; Zaja, Francesco; Quinson, Anne-Marie; Belsack, Valérie; Maier, Daniela; Carlo-Stella, Carmelo
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogenic stem call transplantation from a HLA identical sibling
2018-01-01 Sarina, B; Mariotti, J; Bramanti, S; Crocchiolo, R; Rimondo, A; Tordato, F; Pocaterra, D; Casari, E; De Philippis, C; Carlo Stella, C; Santoro, A; Castagna, L
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®)
2009-01-01 Chiesa, C.; Botta, F.; Coliva, A.; Maccauro, M.; Devizzi, L.; Guidetti, A.; Carlo-Stella, C.; Seregni, E.; Gianni, A. M.; Bombardieri, E.
ACQUIRED CYCLIC THROMBOCYTOPENIATHROMBOCYTOSIS WITH PERIODIC DEFECT OF PLATELET-FUNCTION
1993-01-01 Balduini, Cl; CARLO-STELLA, C.; Rosti, V; Bertolino, G; Noris, P; Ascari, E
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH)
2004-01-01 Carlo-Stella, C.; Di Nicola, M.; Milani, R.; Longoni, P.; Milanesi, M.; Bifulco, C.; Stucchi, C.; Guidetti, A.; Cleris, L.; Formelli, F.; Garotta, G.; Gianni, A. M.
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome
2020-01-01 Castagna, Luca; Pagliardini, Thomas; Bramanti, Stefania; Schiano de Colella, Jean Marc; Montes de Oca, Catalina; Bouabdallah, Reda; Mariotti, Jacopo; Fürst, Sabine; Granata, Angela; De Philippis, Chiara; Harbi, Samia; Sarina, Barbara; Legrand, Faezeh; Maisano, Valerio; Weiller, Pierre Jean; Chabannon, Christian; Carlo-Stella, Carmelo; Santoro, Armando; Blaise, Didier; Devillier, Raynier
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
2021-01-01 Merryman, Reid W; Castagna, Luca; Giordano, Laura; Ho, Vincent T; Corradini, Paolo; Guidetti, Anna; Casadei, Beatrice; Bond, David A; Jaglowski, Samantha; Spinner, Michael A; Arai, Sally; Lowsky, Robert; Shah, Gunjan L; Perales, Miguel-Angel; De Colella, Jean Marc Schiano; Blaise, Didier; Herrera, Alex F; Shouse, Geoffrey; Spilleboudt, Chloe; Ansell, Stephen M; Nieto, Yago; Badar, Talha; Hamadani, Mehdi; Feldman, Tatyana A; Dahncke, Lori; Singh, Anurag K; Mcguirk, Joseph P; Nishihori, Taiga; Chavez, Julio; Serritella, Anthony V; Kline, Justin; Mohty, Mohamad; Dulery, Remy; Stamatoulas, Aspasia; Houot, Roch; Manson, Guillaume; Moles-Moreau, Marie-Pierre; Orvain, Corentin; Bouabdallah, Kamal; Modi, Dipenkumar; Ramchandren, Radhakrishnan; Lekakis, Lazaros; Beitinjaneh, Amer; Frigault, Matthew J; Chen, Yi-Bin; Lynch, Ryan C; Smith, Stephen D; Rao, Uttam; Byrne, Michael; Romancik, Jason T; Cohen, Jonathon B; Nathan, Sunita; Phillips, Tycel; Joyce, Robin M; Rahimian, Maryam; Bashey, Asad; Ballard, Hatcher J; Svoboda, Jakub; Torri, Valter; Sollini, Martina; De Philippis, Chiara; Magagnoli, Massimo; Santoro, Armando; Armand, Philippe; Zinzani, Pier Luigi; Carlo-Stella, Carmelo
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma
2021-01-01 Munshi, Pashna N.; Hamadani, Mehdi; Kumar, Ambuj; Dreger, Peter; Friedberg, Jonathan W.; Dreyling, Martin; Kahl, Brad; Jerkeman, Mats; Kharfan-Dabaja, Mohamed A.; Locke, Frederick L.; Shadman, Mazyar; Hill, Brian T.; Ahmed, Sairah; Herrera, Alex F.; Sauter, Craig S.; Bachanova, Veronika; Ghosh, Nilanjan; Lunning, Matthew; Kenkre, Vaishalee P.; Aljurf, Mahmoud; Wang, Michael; Maddocks, Kami J.; Leonard, John P.; Kamdar, Manali; Phillips, Tycel; Cashen, Amanda F.; Inwards, David J.; Sureda, Anna; Cohen, Jonathon B.; Smith, Sonali M.; Carlo-Stella, Carmelo; Savani, Bipin; Robinson, Stephen P.; Fenske, Timothy S.
Amifostine (WR-2721) selective protection against melphalan genotoxicity
2000-01-01 Buschini, A.; Anceschi, E.; Carlo-Stella, C.; Regazzi, E.; Rizzoli, V.; Poli, P.; Rossi, C.
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells
2008-01-01 Carlo Stella, C.; Lavazza, C.; Carbone, A.; Gianni, A. M.
Antitumor activity of adenovirally transduced CD34+ cells expressing membrane-bound TRAIL
2007-01-01 Carlo Stella, C.; Lavazza, C.; Carbone, A.; Gianni, A. M.
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (mTRAIL)
2006-01-01 Carlo-Stella, C.; Lavazza, C.; Di Nicola, M.; Cleris, L.; Longoni, P.; Milanesi, M.; Magni, M.; Morelli, D.; Gloghini, A.; Carbone, A.; Gianni, A. M.
Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-a: evidence for a tyrosine-kinase-dependent process
1995-01-01 Rizzo, M. T.; Boswell, S. H.; Mangoni, L; CARLO-STELLA, C.; Rizzoli, V
Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation sf the c-jun amino-terminal kinases in stromal cells
1996-01-01 Rizzo, Mt; Carlo Stella, C.
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?
2018-01-01 Carbone, A; Gloghini, A; Carlo Stella, C
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
2021-01-01 Munshi, Pashna N.; Hamadani, Mehdi; Kumar, Ambuj; Dreger, Peter; Friedberg, Jonathan W.; Dreyling, Martin; Kahl, Brad; Jerkeman, Mats; Kharfan-Dabaja, Mohamed A.; Locke, Frederick L.; Shadman, Mazyar; Hill, Brian T.; Ahmed, Sairah; Herrera, Alex F.; Sauter, Craig S.; Bachanova, Veronika; Ghosh, Nilanjan; Lunning, Matthew; Kenkre, Vaishalee P.; Aljurf, Mahmoud; Wang, Michael; Maddocks, Kami J.; Leonard, John P.; Kamdar, Manali; Phillips, Tycel; Cashen, Amanda F.; Inwards, David J.; Sureda, Anna; Cohen, Jonathon B.; Smith, Sonali M.; Carlo-Stella, Carmelo; Savani, Bipin; Robinson, Stephen P.; Fenske, Timothy S.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
[Mesenchymal stem cells: biology and clinical applications] | 1-gen-2002 | Carlo-Stella, Carmelo; Di Nicola, Massimo; Gianni, Massimo A | |
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments | 1-gen-2009 | Righi, M.; Giacomini, A.; Lavazza, C.; Sia, D.; Carlo-Stella, C.; Gianni, A. | |
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K delta/gamma Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study | 1-gen-2020 | Carlo Stella, C; Delarue, R; Scarfo, L; Barde, Pj; Nair, A; Locatelli, Sl; Morello, L; Magagnoli, M; Vakkalanka, S; Viswanadha, S; Ferreri, Ajm | |
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma | 1-gen-2019 | Kahl, Bs; Hamadani, M; Radford, J; Carlo Stella, C; Caimi, P; Reid, E; Feingold, Jm; Ardeshna, Km; Solh, M; Heffner, Lt; Ungar, D; He, S; Boni, J; Havenith, K; O'Connor, Oa | |
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma | 1-gen-2021 | Balzarotti, Monica; Magagnoli, Massimo; Canales, Miguel Ángel; Corradini, Paolo; Grande, Carlos; Sancho, Juan-Manuel; Zaja, Francesco; Quinson, Anne-Marie; Belsack, Valérie; Maier, Daniela; Carlo-Stella, Carmelo | |
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogenic stem call transplantation from a HLA identical sibling | 1-gen-2018 | Sarina, B; Mariotti, J; Bramanti, S; Crocchiolo, R; Rimondo, A; Tordato, F; Pocaterra, D; Casari, E; De Philippis, C; Carlo Stella, C; Santoro, A; Castagna, L | |
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®) | 1-gen-2009 | Chiesa, C.; Botta, F.; Coliva, A.; Maccauro, M.; Devizzi, L.; Guidetti, A.; Carlo-Stella, C.; Seregni, E.; Gianni, A. M.; Bombardieri, E. | |
ACQUIRED CYCLIC THROMBOCYTOPENIATHROMBOCYTOSIS WITH PERIODIC DEFECT OF PLATELET-FUNCTION | 1-gen-1993 | Balduini, Cl; CARLO-STELLA, C.; Rosti, V; Bertolino, G; Noris, P; Ascari, E | |
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH) | 1-gen-2004 | Carlo-Stella, C.; Di Nicola, M.; Milani, R.; Longoni, P.; Milanesi, M.; Bifulco, C.; Stucchi, C.; Guidetti, A.; Cleris, L.; Formelli, F.; Garotta, G.; Gianni, A. M. | |
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome | 1-gen-2020 | Castagna, Luca; Pagliardini, Thomas; Bramanti, Stefania; Schiano de Colella, Jean Marc; Montes de Oca, Catalina; Bouabdallah, Reda; Mariotti, Jacopo; Fürst, Sabine; Granata, Angela; De Philippis, Chiara; Harbi, Samia; Sarina, Barbara; Legrand, Faezeh; Maisano, Valerio; Weiller, Pierre Jean; Chabannon, Christian; Carlo-Stella, Carmelo; Santoro, Armando; Blaise, Didier; Devillier, Raynier | |
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma | 1-gen-2021 | Merryman, Reid W; Castagna, Luca; Giordano, Laura; Ho, Vincent T; Corradini, Paolo; Guidetti, Anna; Casadei, Beatrice; Bond, David A; Jaglowski, Samantha; Spinner, Michael A; Arai, Sally; Lowsky, Robert; Shah, Gunjan L; Perales, Miguel-Angel; De Colella, Jean Marc Schiano; Blaise, Didier; Herrera, Alex F; Shouse, Geoffrey; Spilleboudt, Chloe; Ansell, Stephen M; Nieto, Yago; Badar, Talha; Hamadani, Mehdi; Feldman, Tatyana A; Dahncke, Lori; Singh, Anurag K; Mcguirk, Joseph P; Nishihori, Taiga; Chavez, Julio; Serritella, Anthony V; Kline, Justin; Mohty, Mohamad; Dulery, Remy; Stamatoulas, Aspasia; Houot, Roch; Manson, Guillaume; Moles-Moreau, Marie-Pierre; Orvain, Corentin; Bouabdallah, Kamal; Modi, Dipenkumar; Ramchandren, Radhakrishnan; Lekakis, Lazaros; Beitinjaneh, Amer; Frigault, Matthew J; Chen, Yi-Bin; Lynch, Ryan C; Smith, Stephen D; Rao, Uttam; Byrne, Michael; Romancik, Jason T; Cohen, Jonathon B; Nathan, Sunita; Phillips, Tycel; Joyce, Robin M; Rahimian, Maryam; Bashey, Asad; Ballard, Hatcher J; Svoboda, Jakub; Torri, Valter; Sollini, Martina; De Philippis, Chiara; Magagnoli, Massimo; Santoro, Armando; Armand, Philippe; Zinzani, Pier Luigi; Carlo-Stella, Carmelo | |
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma | 1-gen-2021 | Munshi, Pashna N.; Hamadani, Mehdi; Kumar, Ambuj; Dreger, Peter; Friedberg, Jonathan W.; Dreyling, Martin; Kahl, Brad; Jerkeman, Mats; Kharfan-Dabaja, Mohamed A.; Locke, Frederick L.; Shadman, Mazyar; Hill, Brian T.; Ahmed, Sairah; Herrera, Alex F.; Sauter, Craig S.; Bachanova, Veronika; Ghosh, Nilanjan; Lunning, Matthew; Kenkre, Vaishalee P.; Aljurf, Mahmoud; Wang, Michael; Maddocks, Kami J.; Leonard, John P.; Kamdar, Manali; Phillips, Tycel; Cashen, Amanda F.; Inwards, David J.; Sureda, Anna; Cohen, Jonathon B.; Smith, Sonali M.; Carlo-Stella, Carmelo; Savani, Bipin; Robinson, Stephen P.; Fenske, Timothy S. | |
Amifostine (WR-2721) selective protection against melphalan genotoxicity | 1-gen-2000 | Buschini, A.; Anceschi, E.; Carlo-Stella, C.; Regazzi, E.; Rizzoli, V.; Poli, P.; Rossi, C. | |
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells | 1-gen-2008 | Carlo Stella, C.; Lavazza, C.; Carbone, A.; Gianni, A. M. | |
Antitumor activity of adenovirally transduced CD34+ cells expressing membrane-bound TRAIL | 1-gen-2007 | Carlo Stella, C.; Lavazza, C.; Carbone, A.; Gianni, A. M. | |
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (mTRAIL) | 1-gen-2006 | Carlo-Stella, C.; Lavazza, C.; Di Nicola, M.; Cleris, L.; Longoni, P.; Milanesi, M.; Magni, M.; Morelli, D.; Gloghini, A.; Carbone, A.; Gianni, A. M. | |
Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-a: evidence for a tyrosine-kinase-dependent process | 1-gen-1995 | Rizzo, M. T.; Boswell, S. H.; Mangoni, L; CARLO-STELLA, C.; Rizzoli, V | |
Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation sf the c-jun amino-terminal kinases in stromal cells | 1-gen-1996 | Rizzo, Mt; Carlo Stella, C. | |
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade? | 1-gen-2018 | Carbone, A; Gloghini, A; Carlo Stella, C | |
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma | 1-gen-2021 | Munshi, Pashna N.; Hamadani, Mehdi; Kumar, Ambuj; Dreger, Peter; Friedberg, Jonathan W.; Dreyling, Martin; Kahl, Brad; Jerkeman, Mats; Kharfan-Dabaja, Mohamed A.; Locke, Frederick L.; Shadman, Mazyar; Hill, Brian T.; Ahmed, Sairah; Herrera, Alex F.; Sauter, Craig S.; Bachanova, Veronika; Ghosh, Nilanjan; Lunning, Matthew; Kenkre, Vaishalee P.; Aljurf, Mahmoud; Wang, Michael; Maddocks, Kami J.; Leonard, John P.; Kamdar, Manali; Phillips, Tycel; Cashen, Amanda F.; Inwards, David J.; Sureda, Anna; Cohen, Jonathon B.; Smith, Sonali M.; Carlo-Stella, Carmelo; Savani, Bipin; Robinson, Stephen P.; Fenske, Timothy S. |